Aadi Bioscience, Inc.

AADINASDAQHealthcare

$2.05

$-0.05(-2.38%)

Market Cap$94891630

P/E Ratio—

52W High$3.812

52W Low$1.21

Avg Volume201K

Open$2.15

Beta0.34

Insider Trades Ownership Employees

Aadi Bioscience, Inc. (AADI) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · AADI · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Aadi Bioscience, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

AADI insider buying and selling by quarter

AADI insider selling · AADI insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

13.6M6.8M0

2023 Q2

2023 Q3

2023 Q4

2024 Q1

2024 Q2

2024 Q3

2024 Q4

2025 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

AADI executive sell shares · AADI board member insider trading · AADI insider trading SEC filing

Showing 55 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Mar 4, 2025	Dalal Anupam Director	Award	1,561,000	$2.40	$3.75M⚡	3,410,402	Form 4
Mar 4, 2025	Castelein Caley Director	Award	1,666,000	$2.40	$4.00M⚡	2,165,998	Form 4
Mar 4, 2025	Zhao Baiteng Director	Award	1,250,000	$2.40	$3.00M⚡	1,250,000	Form 4
Mar 4, 2025	BALL BRYAN See remarks	Award	100,000	$2.40	$240K	202,853	Form 4
Mar 1, 2025	BALL BRYAN See remarks	Option	5,000	—	—	105,000	Form 4
Mar 3, 2025	BALL BRYAN See remarks	Sale	2,147	$2.35	$5K	102,853	Form 4
Mar 1, 2025	Giacobello Scott M. CHIEF FINANCIAL OFFICER	Option	6,750	—	—	26,750	Form 4
Mar 3, 2025	Giacobello Scott M. CHIEF FINANCIAL OFFICER	Sale	2,806	$2.35	$7K	23,944	Form 4
Mar 1, 2025	Lennon David James CHIEF EXECUTIVE OFFICER · Director	Option	16,250	—	—	39,119	Form 4
Mar 3, 2025	Lennon David James CHIEF EXECUTIVE OFFICER · Director	Sale	5,690	$2.35	$13K	33,429	Form 4
Oct 2, 2024	Lennon David James CHIEF EXECUTIVE OFFICER · Director	Option	32,558	—	—	32,558	Form 4
Oct 3, 2024	Lennon David James CHIEF EXECUTIVE OFFICER · Director	Sale	9,689	$1.94	$19K	22,869	Form 4
Sep 3, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	40,000	$1.71	$68K	1,171,543	Form 4
Aug 1, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	15,415	$1.50	$23K	1,236,128	Form 4
Aug 2, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	18,933	$1.41	$27K	1,217,195	Form 4
Aug 5, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	5,652	$1.34	$8K	1,211,543	Form 4
Jul 1, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	31,348	$1.45	$46K	1,260,195	Form 4
Jul 2, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	8,652	$1.34	$12K	1,251,543	Form 4
Jun 3, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	19,775	$1.81	$36K	1,311,768	Form 4
Jun 4, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	20,225	$1.77	$36K	1,291,543	Form 4
May 1, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	40,000	$1.93	$77K	1,331,543	Form 4
Apr 1, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	17,772	$2.31	$41K	1,393,771	Form 4
Apr 2, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	22,228	$2.23	$50K	1,371,543	Form 4
Mar 1, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	27,036	$1.97	$53K	1,426,507	Form 4
Mar 4, 2024	Desai Neil EXECUTIVE CHAIRMAN · Director	Sale	14,964	$2.10	$31K	1,411,543	Form 4

Dalal Anupam

Director

Award

Date

Mar 4

1,561,000

Price

$2.40

Value

$3.75M ⚡

View Form 4 on SEC.gov

Castelein Caley

Director

Award

Date

Mar 4

1,666,000

Price

$2.40

Value

$4.00M ⚡

View Form 4 on SEC.gov

Zhao Baiteng

Director

Award

Date

Mar 4

1,250,000

Price

$2.40

Value

$3.00M ⚡

View Form 4 on SEC.gov

BALL BRYAN

See remarks

Award

Date

Mar 4

100,000

Price

$2.40

Value

$240K

View Form 4 on SEC.gov

BALL BRYAN

See remarks

Option

Date

Mar 1

5,000

Price

—

Value

—

View Form 4 on SEC.gov

BALL BRYAN

See remarks

Sale

Date

Mar 3

2,147

Price

$2.35

Value

$5K

View Form 4 on SEC.gov

Giacobello Scott M.

CHIEF FINANCIAL OFFICER

Option

Date

Mar 1

6,750

Price

—

Value

—

View Form 4 on SEC.gov

Giacobello Scott M.

CHIEF FINANCIAL OFFICER

Sale

Date

Mar 3

2,806

Price

$2.35

Value

$7K

View Form 4 on SEC.gov

Lennon David James

CHIEF EXECUTIVE OFFICER · Director

Option

Date

Mar 1

16,250

Price

—

Value

—

View Form 4 on SEC.gov

Lennon David James

CHIEF EXECUTIVE OFFICER · Director

Sale

Date

Mar 3

5,690

Price

$2.35

Value

$13K

View Form 4 on SEC.gov

Lennon David James

CHIEF EXECUTIVE OFFICER · Director

Option

Date

Oct 2

32,558

Price

—

Value

—

View Form 4 on SEC.gov

Lennon David James

CHIEF EXECUTIVE OFFICER · Director

Sale

Date

Oct 3

9,689

Price

$1.94

Value

$19K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Sep 3

40,000

Price

$1.71

Value

$68K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Aug 1

15,415

Price

$1.50

Value

$23K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Aug 2

18,933

Price

$1.41

Value

$27K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Aug 5

5,652

Price

$1.34

Value

$8K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Jul 1

31,348

Price

$1.45

Value

$46K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Jul 2

8,652

Price

$1.34

Value

$12K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Jun 3

19,775

Price

$1.81

Value

$36K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Jun 4

20,225

Price

$1.77

Value

$36K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

May 1

40,000

Price

$1.93

Value

$77K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Apr 1

17,772

Price

$2.31

Value

$41K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Apr 2

22,228

Price

$2.23

Value

$50K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Mar 1

27,036

Price

$1.97

Value

$53K

View Form 4 on SEC.gov

Desai Neil

EXECUTIVE CHAIRMAN · Director

Sale

Date

Mar 4

14,964

Price

$2.10

Value

$31K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About AADI insider trading

AADI insider trades

Aadi Bioscience, Inc. (AADI) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including AADI. Over the past 12 months, 0 insiders have filed transactions with the SEC. AADI insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Aadi Bioscience, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

AADI insider trading · 5 questions

The insiders of Aadi Bioscience, Inc. (AADI) include executives and directors such as AADI, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

AADI board member insider tradingwho are AADI insidersAADI insider rosterAadi Bioscience, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026